Joshua A. Friedlander
Papers
1
Total Citations
30
H-Index
1
About
Joshua A. Friedlander is a urologic oncologist whose research focuses on optimizing treatment for renal tumors, particularly through cost-effectiveness and comparative effectiveness analyses. His most cited work, "Percutaneous Cryoablation vs Partial Nephrectomy: Cost Comparison of T1a Tumors" (2015, 30 citations), provides critical insights into the economic implications of minimally invasive treatments for small renal masses. By retrospectively comparing hospital costs and clinical outcomes across 165 patients—including percutaneous cryoablation, open, and robot-assisted partial nephrectomy—Friedlander demonstrated that cryoablation offers a significant cost advantage without compromising oncologic control. This study has been influential in guiding clinical decision-making and resource allocation in urologic oncology. Beyond this landmark paper, his broader contributions include advancing the evidence base for nephron-sparing surgery and minimally invasive techniques, helping to shape modern treatment paradigms for T1a renal tumors. Friedlander’s work is essential reading for clinicians and researchers seeking to balance clinical efficacy with economic sustainability in cancer care.
Research Focus
Key Achievements
Top Papers
- 1